Two Sigma Securities, LLC Editas Medicine, Inc. Put Options Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2021

May 17, 2021
SELL
$39.71 - $90.58 $468,578 - $1.07 Million
-11,800 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$27.07 - $84.35 $319,426 - $995,329
11,800 New
11,800 $827,000
Q1 2020

May 15, 2020
SELL
$14.88 - $32.78 $181,536 - $399,916
-12,200 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$19.49 - $32.63 $237,777 - $398,086
12,200 New
12,200 $361,000

Others Institutions Holding EDIT

# of Institutions
248
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $99.7M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email